Phenotypic variations and differential migration of NIH:OVCAR-3 ovarian carcinoma cells isolated from athymic mice
- PMID: 7750204
- DOI: 10.1007/BF00132204
Phenotypic variations and differential migration of NIH:OVCAR-3 ovarian carcinoma cells isolated from athymic mice
Abstract
Transplantation of the human ovarian adenocarcinoma cell line, NIH:OVCAR-3 into athymic mice produces two morphologically distinct tumor cell populations (ascites and solid tumors). In the present study, we isolated both tumor cell phenotypes and investigated their relative malignant potential. Since cytoskeletal and morphological changes correlate with metastatic phenotype, expression of the intermediate-filament protein vimentin was compared between ascites and solid tumors. Ascites tumor cells showed a less differentiated epithelial morphology and concurrently expressed higher levels of vimentin. Ascites cells were more efficient in anchorage independent growth when compared with their solid tumor counterpart. Ascites tumor cells were also highly motile compared with the solid tumor cell population (P = 0.006). Migration of ascites tumor cells was further enhanced by type IV collagen, hyaluronic acid, and chondroitin sulfate A. Solid tumor cells removed from the same animal, however, were not significantly affected by these agents. From these studies, we conclude that ovarian cancer cells present in ascites are phenotypic variants which are highly motile compared with solid tumor cells isolated from the same animal. Ascites tumor cells with increased motility may contribute to peritoneal seeding and metastasis.
Similar articles
-
Invasion of interstitial matrix by a novel cell line from primary peritoneal carcinosarcoma, and by established ovarian carcinoma cell lines: role of cell-matrix adhesion molecules, proteinases, and E-cadherin expression.Gynecol Oncol. 2003 Apr;89(1):60-72. doi: 10.1016/s0090-8258(02)00152-x. Gynecol Oncol. 2003. PMID: 12694655
-
Differential expression of the cell-cell adhesion molecule E-cadherin in ascites and solid human ovarian tumor cells.Int J Cancer. 1994 Aug 1;58(3):393-9. doi: 10.1002/ijc.2910580315. Int J Cancer. 1994. PMID: 7519585
-
Hospicells (ascites-derived stromal cells) promote tumorigenicity and angiogenesis.Int J Cancer. 2010 May 1;126(9):2090-101. doi: 10.1002/ijc.24886. Int J Cancer. 2010. PMID: 19739074
-
Metabolic factors contribute to T-cell inhibition in the ovarian cancer ascites.Int J Cancer. 2020 Oct 1;147(7):1768-1777. doi: 10.1002/ijc.32990. Epub 2020 Apr 25. Int J Cancer. 2020. PMID: 32208517 Free PMC article. Review.
-
Growth factors in human ovarian cancer.Cancer Treat Rev. 1997 Mar;23(2):113-31. doi: 10.1016/s0305-7372(97)90024-4. Cancer Treat Rev. 1997. PMID: 9225962 Review. No abstract available.
Cited by
-
Specific thiazolidinediones inhibit ovarian cancer cell line proliferation and cause cell cycle arrest in a PPARγ independent manner.PLoS One. 2011 Jan 21;6(1):e16179. doi: 10.1371/journal.pone.0016179. PLoS One. 2011. PMID: 21283708 Free PMC article.
-
Acidic glycosaminoglycans of abdominal mucin in a case of pseudomyxoma peritonei caused by appendiceal cancer.Dig Dis Sci. 1999 Nov;44(11):2231-4. doi: 10.1023/a:1026648519050. Dig Dis Sci. 1999. PMID: 10573367
-
A novel tumor-immune microenvironment (TIME)-on-Chip mimics three dimensional neutrophil-tumor dynamics and neutrophil extracellular traps (NETs)-mediated collective tumor invasion.Biofabrication. 2021 Apr 8;13(3):10.1088/1758-5090/abe1cf. doi: 10.1088/1758-5090/abe1cf. Biofabrication. 2021. PMID: 33524968 Free PMC article.
-
CCL25-CCR9 interaction modulates ovarian cancer cell migration, metalloproteinase expression, and invasion.World J Surg Oncol. 2010 Jul 22;8:62. doi: 10.1186/1477-7819-8-62. World J Surg Oncol. 2010. PMID: 20649989 Free PMC article.
-
All trans-retinoic acid analogs promote cancer cell apoptosis through non-genomic Crabp1 mediating ERK1/2 phosphorylation.Sci Rep. 2016 Mar 3;6:22396. doi: 10.1038/srep22396. Sci Rep. 2016. PMID: 26935534 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical